NY-KODAK-MOMENTS
18.11.2020 09:02:13 CET | Business Wire | Press release
Kodak Moments , a leading global provider of photo products and services to retailers, consumers, and entertainment properties, has partnered with diconium on its New Retail 2020 report , which brings emerging technologies and data together with people, architecture and retail culture. As a report sponsor, Kodak Moments continues its investment in forward-looking retail trends, seeking to shift retail from purely a transaction into an emotional experience for customers.
During the global pandemic, the New Retail 2020 report was curated based on discovery tours and discussions with trend institutes and innovative makers to identify critical drivers that will help retail transform into the future. The “new normal” provides retailers an opportunity to adopt strategies to keep up with an ever-changing environment. One of the key takeaways for retailers: Scaling digital capabilities will allow retail to capitalize on future opportunities and protect their businesses from risks.
“We are delighted to be a part of the New Retail 2020 report at such a crucial time for the retail industry,” said Helena Babic, Global Retail Experience Director at Kodak Moments. “As we continue to see trends such as digitization, AI, and emotional shop design become increasingly important for retail adoption, these kinds of insights are especially crucial.”
“Adaptability is one of the most valuable skills for brands and physical retail in general. Be it the digital transformation with its indispensable technologies, or the current crisis, retail is facing one of the greatest challenges in decades,” said Marcus Worbs, Managing Director at diconium strategy. “Together with industry experts, diconium has developed digital solutions to support companies to constantly adapt and transform their business.”
This is the fourth annual report of its kind. In addition to Kodak Moments, partners include Visplay, Outletcity Metzingen and commercetools. To download the full report, visit the diconium website .
About diconium
As an expert for the entire process of digital transformation, diconium has been supporting industry leaders such as VW, Mercedes-Benz, Kodak Alaris or Sick in developing their digital potential and in offering millions of customers extraordinary experiences since 1995. diconium accompanies companies through the entire process of digitization: From innovation & strategy, UX, data & KI, commerce and technology to the development of digital units. diconium is a subsidiary of the Volkswagen Group.
About Kodak Moments
Kodak Moments is a leading global provider of photo products and services to retailers, consumers, and entertainment properties. We inspire consumers to bring their memories to life—delivering innovative, high-quality photo products and experiences they find truly meaningful. Powered by over 100,000 consumer touchpoints across 30 countries globally, it’s our mission to be the brand consumers choose to celebrate and preserve life’s memories, from the big events to the everyday moments that matter.
© 2020 Kodak Moments Division, Kodak Alaris Inc. The Kodak trademark and trade dress are used under license from Eastman Kodak Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201118005064/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom